SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial. [electronic resource]
Producer: 20190128Description: 5 p. digitalISSN:- 1475-2840
- Aged
- Benzhydryl Compounds -- adverse effects
- Blood Glucose -- drug effects
- Blood Pressure -- drug effects
- Cross-Over Studies
- Diabetes Mellitus, Type 2 -- blood
- Double-Blind Method
- Female
- Germany
- Glucosides -- adverse effects
- Humans
- Male
- Middle Aged
- Muscle, Skeletal -- drug effects
- Prospective Studies
- Skin -- drug effects
- Sodium -- metabolism
- Sodium-Glucose Transporter 2 -- drug effects
- Sodium-Glucose Transporter 2 Inhibitors -- adverse effects
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.